| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 10/01/2008 | CN101273773A Health-care Chinese herbal medicine seasoning sauces |
| 10/01/2008 | CN101273745A Health care tea for moistening intestines |
| 10/01/2008 | CN101273744A Method for processing Seabuckthorn tea drinks and seabuckthorn tea drinks using this method |
| 10/01/2008 | CN100422315C Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 10/01/2008 | CN100422309C Use of plant lactobacillus ST-III in fat-reduction |
| 10/01/2008 | CN100422212C Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 10/01/2008 | CN100422179C 2-amino-5-benzoylthiazole npy antagonists |
| 10/01/2008 | CN100422164C Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 10/01/2008 | CN100422150C 2-hydroxymethyl-3,4,5-trihydroxy-1-(4-pentlyoxybenzyl)piperidine as glucosylceramide synthase (GCS) inhibitor |
| 10/01/2008 | CN100422149C 2-hydroxymethyl-3,4,5-trihydroxy-1benzylpiperidine derivatives as inhibitors of glucosylceramide synthase (gcs) |
| 10/01/2008 | CN100421729C Effervescence tablet of human antalzyme, its preparation and usage |
| 10/01/2008 | CN100421689C Preparation technology of crataegus total phenolic acid portion and application |
| 10/01/2008 | CN100421675C Zinc replenisher with control released zinc and its preparing method and use |
| 10/01/2008 | CN100421667C Method for treating and preventing hyperparathyroidism |
| 10/01/2008 | CN100421659C Compositions and methods for lowering plasma lipoprotein (a) and risk factors of cardiovascular diseases |
| 09/30/2008 | US7429663 7-(Pyrimidin-4-yl)-Imidazo[1,2-a]Pyrimidin-5(1H)-ones as GSK3β inhibitors |
| 09/30/2008 | US7429618 substituted triarylmethane compounds for immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 09/30/2008 | US7429614 Medicament containing an effector of the glutathione metabolism together with α-lipoic acid for treating diabetes mellitus |
| 09/30/2008 | US7429612 Indoline compound and medicinal use thereof |
| 09/30/2008 | US7429599 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK |
| 09/30/2008 | US7429578 e.g. phenyl-3,4-dihydropyrrolo[4,3,2-de]isoquinolin-5-(1H)-one; anticarcinogenic agent; stroke, head trauma, and neurodegenerative disease; potentiating cytotoxicity of a DNA-damaging cytotoxic agent or ionizing radiation |
| 09/30/2008 | US7429576 treatment for osteoporosis, hypercholesterolemia, hyperlipidemia, atherosclerosis, breast cancer, endometrial cancer, ovarian cancer and uterine cancer while minimizing undesirable side effects |
| 09/30/2008 | US7429573 Osteoporosis |
| 09/30/2008 | US7429568 Antidiabetic agents; human SGLT2 (sodium ion / glucose cotransporter 2) inhibitors; hyperglycemia, obesity; 3-(6-O-ethoxycarbonyl- beta -D-glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole |
| 09/30/2008 | US7429564 Orally administering insulin and delivery agent 4-[(4-chloro, 2-hydroxybenzoyl)amino]butanoic acid that facilitates the absorption of insulin from the gastrointestinal tract; diabetes mellitus; bioavailability comparable to injection; treating diabetes without the drawbacks of systemic hyperglycemia |
| 09/30/2008 | US7429488 Method for processing lipoaspirate cells |
| 09/30/2008 | CA2450772C Composition for epigallocatechin gallate |
| 09/30/2008 | CA2382480C Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof |
| 09/30/2008 | CA2355470C Benzoheterocycles and their use as mek inhibitors |
| 09/30/2008 | CA2313642C Pharmaceutical hydrogel formulations, drug delivery devices and methods |
| 09/30/2008 | CA2297834C Chromium/biotin treatment of type ii diabetes |
| 09/30/2008 | CA2183050C Sulfonyl- or sulfinylbenzoylguanidine derivatives |
| 09/27/2008 | CA2584494A1 Vector encoding therapeutic polypeptide and safety elements to clear transduced cells |
| 09/25/2008 | WO2008116195A2 Compositions comprising an sglt2 ingibitor for treating obesity |
| 09/25/2008 | WO2008116179A1 Pharmaceutical formulations containing dapagliflozin propylene glycol hydrate |
| 09/25/2008 | WO2008116145A2 Soluble epoxide hydrolase inhibitors |
| 09/25/2008 | WO2008115723A1 Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
| 09/25/2008 | WO2008115141A1 4, 5-dihydro-1,3-thiazol-2-amine derivatives and their use in the treatment of respiratory, cardiovascular, neurological or gastrointestinal disorders |
| 09/25/2008 | WO2008115098A2 Substituted 2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indoles, methods for the production and the use thereof |
| 09/25/2008 | WO2008115062A1 Cereal-based infant nutrition with fibre |
| 09/25/2008 | WO2008115055A2 Rhodospirillum and phaeospirillum in animal feed for the purpose of obtaining food products with a reduced cholesterol level |
| 09/25/2008 | WO2008115046A1 Cereal-based infant nutrition with fibre |
| 09/25/2008 | WO2008114857A1 Method for producing aminoacetylpyrrolidinecarbonitrile derivative |
| 09/25/2008 | WO2008114819A1 Novel adenine compound |
| 09/25/2008 | WO2008114817A1 Novel adenine compound |
| 09/25/2008 | WO2008114807A1 Weekly administration of dipeptidyl peptidase inhibitors |
| 09/25/2008 | WO2008114679A1 Bone metabolism ameliorating agent |
| 09/25/2008 | WO2008114536A1 Dehydroepiandrosterone production promoter and use thereof |
| 09/25/2008 | WO2008113862A2 Composition useful for the prevention of type 2 diabetes and its complications in pre-diabetic patients with insulin resistance |
| 09/25/2008 | WO2008097428A3 Compounds and compositions as modulators of gpr119 activity |
| 09/25/2008 | WO2008096021A3 Process for continuous production of lovastatine |
| 09/25/2008 | WO2008091624A3 Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof |
| 09/25/2008 | WO2008066776A3 Methods for treating hypercholesterolemia |
| 09/25/2008 | WO2007120655A3 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators |
| 09/25/2008 | WO2007042272A3 Use of a nutraceutical composition comprising resveratrol for the treatment of age-related diseases |
| 09/25/2008 | US20080234656 Method for altering drug pharmacokinetics based on medical delivery platform |
| 09/25/2008 | US20080234467 Modifying amino acid sequences conjugate comprising: coupling N- alpha -protected amino acid to an immobilized peptide sequence, deprotecting sequence, cleaving peptide conjugate, recovering product |
| 09/25/2008 | US20080234381 1-Hydroxy-naphthalene-2-carboxylic acid(4-cyano-2-trifluoromethoxy-phenyl)-amide; obesity, atherosclerosis, hypertension, type 2 diabetes, dyslipidemia, coronary heart disease, osteoarthritis, gallbladder disease, endometrial cancer, breast cancer, prostate cancer, colon cancer, |
| 09/25/2008 | US20080234375 Process for Decreasing Environmental Pollutants in an Oil or a Fat, a Volatile Environmental Pollutants Decreasing Working Fluid, a Health Supplement, and an Animal Feed Product |
| 09/25/2008 | US20080234367 Methods for Treating Obesity Employing an SGLT2 Inhibitor and Compositions Thereof |
| 09/25/2008 | US20080234366 Pharmaceutical formulation containing an sglt2 inhibitor |
| 09/25/2008 | US20080234364 Composition and method for treating diabetes and metabolic disorders |
| 09/25/2008 | US20080234361 Mixture of conjugated fatty acid(punicic acid) and polyphenol(ellagic acid); obesity, diabetes, cancer and heart disease |
| 09/25/2008 | US20080234355 Dna methyl transferase inhibitors containing a zinc binding moiety |
| 09/25/2008 | US20080234354 Administering (+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane alone or in combination with a second antiappetite or antiobesity agent; treating or preventing disorders related to or complicated by obesity |
| 09/25/2008 | US20080234351 Treating diabetic retinopathy, particularly moderately to very severe non-proliferative diabetic retinopathy, by administering ruboxistaurin or a salt such as mesylate conjunction with focal or grid laser photocoagulation |
| 09/25/2008 | US20080234349 PPAR active compounds |
| 09/25/2008 | US20080234348 3-Oxoindazolesquaric Acid Derivatives |
| 09/25/2008 | US20080234324 Piperidine Derivatives as Gcs Inhibitors |
| 09/25/2008 | US20080234307 Novel 6-Amino-Morphinan Derivatives, Method of Manufacturing Them and Their Application as Analgesics |
| 09/25/2008 | US20080234302 Novel Processes for Preparing Amorphous Rosuvastatin Calcium and a Novel Polymorphic Form of Rosuvastatin Sodium |
| 09/25/2008 | US20080234301 Alpha-4 Integrin Mediated Cell Adhesion Inhibitors for the Treatment or Prevention of Inflammatory Diseases |
| 09/25/2008 | US20080234292 Such as S)-(1-(1-Aminobicyclo[2.2.2]oct-4-yl)aminoacetyl)-2-cyanopyrrolidine; inhibitors of the enzyme dipeptidyl peptidase; antidiabetic agents |
| 09/25/2008 | US20080234291 Apolipo-protein B (apoB) secretion and microsomal triglyceride transfer protein (MTP) inhibiting properties; hyperlipidemia, obesity, or type II diabetes; solubility, taste modifying agent and an antioxidant |
| 09/25/2008 | US20080234289 Melanocortin Receptor-Specific Compounds |
| 09/25/2008 | US20080234285 Renin inhibitor such as (S),4(S),5(S),7(S) N-(3-amino-2,2-dimethyl-3-oxopropyl)-2,7-di(1-methylethyl)-4-hydroxy-5-amino-8-[4-methoxy-3-(3-methoxy-propoxy)phenyl]-octanamide and PDGF receptor tyrosine kinase inhibitor such as Imatinib, thrombosis, psoriasis, fibrosis, dermatosclerosis, atherosclerosis |
| 09/25/2008 | US20080234282 Especially 1-(2-(naphthylmethoxy)-1-phenylethyl)piperazine derivatives: 4-{[2-(3,chloro-4-fluorophenyl)-2-piperazin-1-ylethoxy]methyl}-3-methoxy-2-naphthonitrile; neurokinin 1 antagonists; antidepressants |
| 09/25/2008 | US20080234273 Such as 3-{[4-(azetidin-1-ylcarbonyl)-2-chlorophenyl]oxy}-5-({(1S)-2-[(difluoromethyl)oxy]-1-methylethyl}oxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinases (Glk) |
| 09/25/2008 | US20080234266 Squaric Acid Derivatives II |
| 09/25/2008 | US20080234259 CB2 agonists; pain, neurodegenative disorders, eating disorders, weight loss or control, obesity, dyslipidemia, drug abuse, vision defect, neurodegenerative diseases; 5-(2,4-difluorophenyl)-4,5-diazatricyclo[5.2.1.0.sup.2,6.]deca-2-(6),3-dien-3-yl-phenylmethanone; antiinflammatory agent, antidepressant |
| 09/25/2008 | US20080234258 Dihydroxyanthraquinones and Their Use |
| 09/25/2008 | US20080234214 Seven or more contiguous ribose groups linked by achiral 5' to 3' internucleoside phosphate linkages; antisense agents for gene expression inhibition of a wide variety of pathological disorders such as autoimmune diseases; suitable for oral administration |
| 09/25/2008 | US20080234207 Antidiabetic agent, blood glucose control abnormality; ginsenosides Rg3, Rg5, and Rk1 from natural substances |
| 09/25/2008 | US20080234206 Prodrugs of Phentermine |
| 09/25/2008 | US20080234202 Reacting carboxylic acid or amide derivative with amine compound to obtain amino acid analogs, peptides containing analogs of basic amino acids lysine and arginine; desamino amino acid compound, of the extended or truncated peptide; pain, psychosis, obesity; cosmetics |
| 09/25/2008 | US20080234200 Saline formulation of a glucose-regulating peptide (amylin, synthtic hormone pramlintide, glucon like peptide-1, extendins), water, sodium chloride and a buffering agent; identical ph and osmolarity for both transmucosal glucose regulating peptide and saline water; antidiabetic, antiobesity agent |
| 09/25/2008 | US20080234199 Chemical Compounds |
| 09/25/2008 | US20080234197 Method(s) of stabilizing and potentiating the actions and administration of brain-derived neurotrophic factor (BDNF) |
| 09/25/2008 | US20080234183 Predicting or designing, detecting, and/or verifying a novel cell-penetrating peptide that mimics cellular effector activity; vectors; treating and/or preventing infectious diseases, diabetes type I and II, Alzheimer's Disease, Parkinson's Disease, and cancer. |
| 09/25/2008 | US20080233219 Carbon-coated particle produced by covering an essential oil adsorbent with neroli oil or jasmine oil, and then further covering particle with an essential oil adsorbing and desorbing regulator; obesity remedy for people whose obesity is mild to moderate; high safety |
| 09/25/2008 | US20080233182 Organic compounds |
| 09/25/2008 | US20080233163 4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenylamine; N-{4-[4-Methyl-5-(2-nitrooxy-ethyl)-thiazol-2-yl]-phenyl}-acetamide; or4-Methyl-5-(2-nitrooxy-ethyl)-2-(4-nitro-phenyl)-thiazole; cardiovascular, gastrointestinal, inflammatory, respiratory disease |
| 09/25/2008 | US20080233127 Imidazolopyrimidine analogs and their use as pi3 kinase and mtor inhibitors |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233092 a lactose reduced dairy product such as fluid milk, a smoothie, a liquado, ice cream, yogurt or yogurt drink and an effective amount of a probiotic lactobacillus, bifidobacteria and carbohydrate polymer as prebiotics |
| 09/25/2008 | US20080233087 Methods for identifying, isolating, and utilizing endocrine progenitor cells from adult human pancreata |
| 09/25/2008 | US20080233073 Administering potassium binding polymer of alpha-fluoroacrylic acid comprising counterion of calcium crosslinked with divinylbenzene, (m)ethylenebisacrylamide, N,N'-bis(vinylsulfonylacetyl) ethylene diamine, 1,3-bis(vinylsulfonyl) 2-propanol, vinylsulfone, polyvinyl ether, polyallylether; hyperkalemia |
| 09/25/2008 | DE102007015701A1 Neue pharmazeutische Zusammensetzungen für die Lipolyse und Verfahren zu deren Herstellung Novel pharmaceutical compositions for the lipolysis and processes for their preparation |
| 09/25/2008 | CA2685031A1 Composition for treating diabetes and metabolic disorders with quercetin, myrcetin and chlorogenic acid |
| 09/25/2008 | CA2681715A1 Cereal-based infant nutrition with fibre |